Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Sees Large Decline in Short Interest

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 1,804,605 shares, a decrease of 72.7% from the April 30th total of 6,612,971 shares. Based on an average trading volume of 1,881,607 shares, the short-interest ratio is currently 1.0 days. Currently, 0.3% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to data from MarketBeat.com, Curaleaf presently has an average rating of “Strong Buy”.

Curaleaf Trading Down 1.5%

CURLF stock traded down $0.06 during trading on Friday, hitting $3.51. The company had a trading volume of 1,150,194 shares, compared to its average volume of 1,225,009. The business has a 50-day moving average of $2.97 and a 200-day moving average of $2.68. Curaleaf has a one year low of $0.72 and a one year high of $5.05. The stock has a market cap of $2.45 billion, a PE ratio of -26.96 and a beta of 1.58. The company has a current ratio of 1.56, a quick ratio of 0.74 and a debt-to-equity ratio of 1.05.

Shares of Curaleaf are going to reverse split before the market opens on Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 4th.

Curaleaf (OTCMKTS:CURLF) last announced its earnings results on Tuesday, May 5th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. Research analysts predict that Curaleaf will post -0.1 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.